SCHEMBL20074252

SCHEMBL20074252

CC(C)c1c(-c2cccc(Oc3ccccc3)c2)[nH]c2ncnn2c1=O

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM5B Q9UGL1 3/20 0.52
GRIN2D O15399 5/20 0.39
GRIN3B O60391 5/20 0.39
GRIN1 Q05586 5/20 0.39
GRIN2A Q12879 5/20 0.39
GRIN2B Q13224 5/20 0.39
GRIN2C Q14957 5/20 0.39
GRIN3A Q8TCU5 5/20 0.39
PIK3CD O00329 1/20 0.38
PIK3CA P42336 1/20 0.38
PIK3CB P42338 1/20 0.38
PIK3CG P48736 1/20 0.38
PRKDC P78527 1/20 0.38
TDP1 Q9NUW8 1/20 0.37
COMT P21964 1/20 0.37
TSHR P16473 1/20 0.36
DHODH Q02127 1/20 0.36
KDM5A P29375 1/20 0.36
PTGS1 P23219 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31676989 1.00 KDM5B (0.52) KDM5BGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL21681717 0.89 KDM5B (0.50) KDM5BTSHR
SCHEMBL20074277 0.86 KDM5B (0.42) KDM5BTDP1TSHRKDM5A
SCHEMBL20074112 0.82 TSHR (0.39) KDM5BPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL21721750 0.82 KDM5B (0.49) KDM5BTSHR
SCHEMBL20074110 0.82 KDM5B (0.48) KDM5BTDP1TSHR
SCHEMBL31676999 0.82 KDM5B (0.49) KDM5BTSHR
SCHEMBL21721688 0.81 KDM5B (0.52) KDM5BPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL20074249 0.80 KDM5B (0.54) KDM5BPRKDCTDP1TSHRDHODH
SCHEMBL31676974 0.80 KDM5B (0.54) KDM5BPRKDCTDP1TSHRDHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10975084-B2 KDM5 inhibitors MERCK SHARP & DOHME CORP. (US) 2021-04-13 US disclosed
US-20200048258-A1 KDM5 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2020-02-13 US disclosed
WO-2018071283-A1 KDM5 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2018-04-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200048258-A1 KDM5 INHIBITORS KDM5A, KDM5B, KDM5C KDM5B 2/4885GRIN2D 4080/4885GRIN3B 3731/4885
US-10975084-B2 KDM5 inhibitors KDM5A, KDM5B, KDM5C KDM5B 2/4885GRIN2D 4080/4885GRIN3B 3731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.